https://news.medxy.ai/zh/bireociclib%e8%81%94%e5%90%88%e6%b0%9f%e7%bb%b4%e5%8f%b8%e7%be%a4%e6%b2%bb%e7%96%97%e5%86%85%e5%88%86%e6%b3%8c%e8%bf%9b%e5%b1%95%e5%90%8e%e7%9a%84%e6%99%9a%e6%9c%9f%e4%b9%b3%e8%85%ba%e7%99%8c%ef%bc%9a/Medxy AIzh2026-05-23T09:21:29-07:00Bireociclib联合氟维司群治疗内分泌进展后的晚期乳腺癌：BRIGHT-2 III期随机临床试验及比较综合分析 https://news.medxy.ai/ja/bireociclib%e3%81%a8%e3%83%95%e3%83%ab%e3%83%99%e3%82%b9%e3%83%88%e3%83%a9%e3%83%b3%e3%83%88%e3%81%ae%e4%bd%b5%e7%94%a8%e6%8a%95%e4%b8%8e%ef%bc%9a%e5%86%85%e5%88%86%e6%b3%8c%e7%99%82%e6%b3%95%e9%80%b2/Medxy AIja2026-05-23T09:20:33-07:00Bireociclibとフルベストラントの併用投与：内分泌療法進行後の進行乳がんに対するBRIGHT-2第3相無作為化臨床試験および比較合成 https://news.medxy.ai/vi/bireociclib-ket-hop-voi-fulvestrant-trong-dieu-tri-ung-thu-vu-tien-trien-sau-khi-noi-tiet-that-bai-thu-nghiem-lam-sang-ngau-nhien-giai-doan-3-bright-2-va-tong-hop-so-sanh/Medxy AIvi2026-05-23T09:19:21-07:00Bireociclib kết hợp với Fulvestrant trong điều trị ung thư vú tiến triển sau khi nội tiết thất bại: Thử nghiệm lâm sàng ngẫu nhiên giai đoạn 3 BRIGHT-2 và tổng hợp so sánh https://news.medxy.ai/bireociclib-plus-fulvestrant-in-advanced-breast-cancer-after-endocrine-progression-the-bright-2-phase-3-randomized-clinical-trial-and-comparative-synthesis/Medxy AIen2026-05-23T09:16:58-07:00Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical Trial and Comparative Synthesis https://news.medxy.ai/health-plan-disenrollment-and-mortality-after-starting-medications-for-opioid-use-disorder/Medxy AIen2026-05-23T09:02:45-07:00Health Plan Disenrollment and Mortality After Starting Medications for Opioid Use Disorder https://news.medxy.ai/ja/%e3%83%99%e3%83%83%e3%83%89%e3%81%8b%e3%82%89%e6%a4%85%e5%ad%90%e3%81%b8%e3%81%ae%e7%a7%bb%e5%8b%95%e3%81%8c%e8%87%aa%e7%99%ba%e5%91%bc%e5%90%b8%e3%81%99%e3%82%8bicu%e6%82%a3%e8%80%85%e3%81%ae/Medxy AIja2026-05-23T09:02:04-07:00ベッドから椅子への移動が自発呼吸するICU患者の酸素化を改善 https://news.medxy.ai/vi/viec-dat-benh-nhan-ra-khoi-giuong-trong-ghe-dai-cai-thien-oxy-hoa-o-benh-nhan-icu-tho-tu-nhien/Medxy AIvi2026-05-23T09:00:57-07:00Việc đặt bệnh nhân ra khỏi giường trong ghế dài cải thiện oxy hóa ở bệnh nhân ICU thở tự nhiên https://news.medxy.ai/out-of-bed-armchair-positioning-improves-oxygenation-in-spontaneously-breathing-icu-patients/Medxy AIen2026-05-23T08:59:24-07:00Out-of-Bed Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients https://news.medxy.ai/zh/%e6%97%a0%e8%ae%ba%e6%98%af%e5%90%a6%e8%99%9a%e5%bc%b1%ef%bc%8cicu-%e5%86%8d%e5%85%a5%e9%99%a2%e5%9d%87%e6%98%be%e8%91%97%e5%a2%9e%e5%8a%a0-60-%e5%a4%a9%e6%ad%bb%e4%ba%a1%e7%8e%87%ef%bc%8c%e4%bd%86/Medxy AIzh2026-05-22T09:22:16-07:00无论是否虚弱，ICU 再入院均显著增加 60 天死亡率，但虚弱患者绝对风险最高 https://news.medxy.ai/ja/icu%e5%86%8d%e5%85%a5%e5%ae%a4%e3%81%af%e8%99%9a%e5%bc%b1%e3%81%ab%e9%96%a2%e3%82%8f%e3%82%89%e3%81%9a60%e6%97%a5%e6%ad%bb%e4%ba%a1%e7%8e%87%e3%82%92%e5%a4%a7%e5%b9%85%e3%81%ab%e4%b8%8a%e6%98%87/Medxy AIja2026-05-22T09:19:56-07:00ICU再入室は虚弱に関わらず60日死亡率を大幅に上昇させるが、虚弱患者の絶対リスクは最も高い https://news.medxy.ai/vi/viec-tai-nhap-vien-icu-lam-tang-dang-ke-ty-le-tu-vong-60-ngay-bat-ke-tinh-trang-suy-giam-nhung-benh-nhan-suy-giam-co-nguy-co-tuyet-doi-cao-nhat/Medxy AIvi2026-05-22T09:17:27-07:00Việc tái nhập viện ICU làm tăng đáng kể tỷ lệ tử vong 60 ngày, bất kể tình trạng suy giảm, nhưng bệnh nhân suy giảm có nguy cơ tuyệt đối cao nhất https://news.medxy.ai/icu-readmission-raises-60-day-mortality-substantially-regardless-of-frailty-but-frail-patients-carry-the-highest-absolute-risk/Medxy AIen2026-05-22T09:12:30-07:00ICU Readmission Raises 60-Day Mortality Substantially Regardless of Frailty, but Frail Patients Carry the Highest Absolute Risk https://news.medxy.ai/ja/%e6%95%91%e6%80%a5%e7%a7%91%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%80%a5%e6%80%a7%e9%9d%9e%e5%a4%96%e5%82%b7%e6%80%a7%e9%a0%ad%e7%97%9b%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e9%9d%99%e8%84%88%e5%86%85/Medxy AIja2026-05-22T08:59:23-07:00救急科における急性非外傷性頭痛に対する静脈内硫酸マグネシウム https://news.medxy.ai/vi/sulfat-magie-tiem-tinh-mach-cho-dau-dau-cap-tinh-khong-chan-thuong-tai-phong-cap-cuu/Medxy AIvi2026-05-22T08:57:35-07:00Sulfat magiê tiêm tĩnh mạch cho đau đầu cấp tính không chấn thương tại phòng cấp cứu https://news.medxy.ai/intravenous-magnesium-sulfate-for-acute-nontraumatic-headache-in-the-emergency-department/Medxy AIen2026-05-22T08:55:41-07:00Intravenous Magnesium Sulfate for Acute Nontraumatic Headache in the Emergency Department https://news.medxy.ai/do-digital-specialist-consults-really-keep-patients-out-of-the-hospital/Medxy AIen2026-05-22T08:40:32-07:00Do Digital Specialist Consults Really Keep Patients Out of the Hospital? https://news.medxy.ai/ja/%e4%b8%80%e6%ac%a1%e8%a8%ba%e7%99%82%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%80%a5%e9%80%9f%e5%91%bc%e5%90%b8%e5%99%a8%e6%a4%9c%e6%9f%bb%e3%81%a8%e6%8a%97%e7%94%9f%e7%89%a9%e8%b3%aa%e3%81%ae%e4%bd%bf/Medxy AIja2026-05-22T08:12:28-07:00一次診療における急速呼吸器検査と抗生物質の使用：無作為化臨床試験 https://news.medxy.ai/vi/kiem-tra-nhanh-tai-diem-cham-soc-ho-hap-va-viec-su-dung-khang-sinh-trong-cham-soc-ban-dau-mot-thu-nghiem-lam-sang-ngau-nhien/Medxy AIvi2026-05-22T08:10:58-07:00Kiểm tra nhanh tại điểm chăm sóc hô hấp và việc sử dụng kháng sinh trong chăm sóc ban đầu: Một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/rapid-respiratory-point-of-care-testing-and-antibiotic-use-in-primary-care-a-randomized-clinical-trial/Medxy AIen2026-05-22T08:08:40-07:00Rapid Respiratory Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial https://news.medxy.ai/ja/acp%e3%81%8c%e3%83%a1%e3%83%87%e3%82%a3%e3%82%b1%e3%82%a2%e3%83%bb%e3%82%a2%e3%83%89%e3%83%90%e3%83%b3%e3%83%86%e3%83%bc%e3%82%b8%e3%81%ae%e7%9b%a3%e8%a6%96%e5%bc%b7%e5%8c%96%e3%82%92%e6%b1%82/Medxy AIja2026-05-22T00:22:46-07:00ACPがメディケア・アドバンテージの監視強化を求める：患者保護、支払いの正確性、および品質向上のため https://news.medxy.ai/vi/acp-keu-goi-giam-sat-chat-che-hon-doi-voi-medicare-advantage-de-bao-ve-benh-nhan-do-chinh-xac-thanh-toan-va-chat-luong/Medxy AIvi2026-05-22T00:19:24-07:00ACP kêu gọi giám sát chặt chẽ hơn đối với Medicare Advantage để bảo vệ bệnh nhân, độ chính xác thanh toán và chất lượng https://news.medxy.ai/zh/acp%e5%91%bc%e5%90%81%e5%8a%a0%e5%bc%ba%e5%af%b9medicare-advantage%e7%9a%84%e7%9b%91%e7%ae%a1%e4%bb%a5%e4%bf%9d%e6%8a%a4%e6%82%a3%e8%80%85%e3%80%81%e6%94%af%e4%bb%98%e5%87%86%e7%a1%ae%e6%80%a7/Medxy AIzh2026-05-22T00:15:57-07:00ACP呼吁加强对Medicare Advantage的监管以保护患者、支付准确性和质量 https://news.medxy.ai/acp-calls-for-stronger-oversight-of-medicare-advantage-to-protect-patients-payment-accuracy-and-quality/Medxy AIen2026-05-22T00:12:35-07:00ACP Calls for Stronger Oversight of Medicare Advantage to Protect Patients, Payment Accuracy, and Quality https://news.medxy.ai/vi/viec-chon-nguoi-hien-te-bao-goc-tai-sao-tuoi-dong-vai-tro-quan-trong-hon-o-mot-so-ghep-so-voi-nhung-ghep-khac/Medxy AIvi2026-05-21T20:25:11-07:00Việc Chọn Người Hiến Tế Bào Gốc: Tại Sao Tuổi Đóng Vai Trò Quan Trọng Hơn Ở Một Số Ghép So Với Những Ghép Khác https://news.medxy.ai/frontline-allogeneic-transplantation-outperforms-pretransplant-ipss-m-downstaging-in-myelodysplastic-neoplasms/Medxy AIen2026-05-21T20:25:06-07:00Frontline Allogeneic Transplantation Outperforms Pretransplant IPSS-M Downstaging in Myelodysplastic Neoplasms https://news.medxy.ai/ja/%e5%b9%b9%e7%b4%b0%e8%83%9e%e3%83%89%e3%83%8a%e3%83%bc%e3%81%ae%e9%81%b8%e6%8a%9e-%e5%b9%b4%e9%bd%a2%e3%81%8c%e7%a7%bb%e6%a4%8d%e3%81%ab%e4%b8%8e%e3%81%88%e3%82%8b%e5%bd%b1%e9%9f%bf/Medxy AIja2026-05-21T20:22:32-07:00幹細胞ドナーの選択: 年齢が移植に与える影響 https://news.medxy.ai/zh/%e9%80%89%e6%8b%a9%e5%b9%b2%e7%bb%86%e8%83%9e%e4%be%9b%e8%80%85%ef%bc%9a%e4%b8%ba%e4%bd%95%e5%9c%a8%e6%9f%90%e4%ba%9b%e7%a7%bb%e6%a4%8d%e4%b8%ad%e5%b9%b4%e9%be%84%e6%9b%b4%e4%b8%ba%e9%87%8d%e8%a6%81/Medxy AIzh2026-05-21T20:20:04-07:00选择干细胞供者：为何在某些移植中年龄更为重要 https://news.medxy.ai/choosing-a-stem-cell-donor-why-age-matters-more-in-some-transplants-than-others/Medxy AIen2026-05-21T20:16:16-07:00Choosing a Stem Cell Donor: Why Age Matters More in Some Transplants Than Others